Effect of Plasma Oncotic Pressure on Apolipoprotein Levels in Rats with Heymann Nephritis

George Kaysen, Hardin Jones, Japp A. Joles, Arie Van Tol

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The nephrotic syndrome is characterized by reduced plasma albumin and colloid osmotic pressure (π). Infusion of dextran or albumin reduces lipid levels suggesting that reduced plasma π plays a role in causing hyperlipidemia in the nephrotic syndrome. To determine whether apolipoprotein (Apo) levels were affected by π, passive Heymann nephritis (HN) was created in 20 rats. Hyperoncotic (25%) human albumin or ficoll was infused continuously into each of 5 HN rats adjusted to maintain a plasma π above 20 mm Hg. Either saline or a mixture of amino acids calculated to approximate those released from catabolized human albumin were infused into 5 HN as controls. Urinary rat albumin loss was not different between the 4 groups of HN. Plasma apo A-I, B and E were all increased significantly in saline and amino acid infused HN, but apo A-IV was decreased. Infusion of either albumin or ficoll normalized apo A-I, and apo E levels in HN even though proteinuria continued unabated. In contrast, apo B remained significantly elevated in HN infused with albumin, but was reduced to normal by ficoll. Fifteen non-nephrotic control animals were studied in 3 groups of 5 animals each; one receiving human albumin, one ficoll, both adjusted to increase plasma π to supranormal levels, and a 3rd group received saline. In contrast to HN, plasma apo A-I, E, and B levels were unaffected by albumin or ficoll infusion in control animals. Ficoll caused a significant reduction in apo A-IV in both HN and control animals to subnormal levels, but albumin infusion was without effect. Reduced plasma π, but not reduced plasma albumin is necessary for increased apo A-I, and E levels in the nephrotic syndrome. When plasma π is normal extensive proteinuria does not increase plasma apo A-I or E levels. Factors other than albumin concentration or π, such as persistent urinary protein loss, play a role in establishing increased apo B containing lipoproteins in the nephrotic syndrome. Ficoll may cause changes in plasma lipoprotein levels by means other than its ability to increase plasma π.

Original languageEnglish (US)
Pages (from-to)31-38
Number of pages8
JournalMineral and Electrolyte Metabolism
Volume22
Issue number1-3
StatePublished - 1996

Fingerprint

Membranous Glomerulonephritis
Apolipoproteins
Ficoll
Rats
Albumins
Plasmas
Pressure
Apolipoprotein A-I
Nephrotic Syndrome
Apolipoproteins E
Animals
Apolipoproteins B
Proteinuria
Serum Albumin
Lipoproteins
Amino Acids
Osmotic Pressure
Colloids
Hyperlipidemias
Dextrans

Keywords

  • Albumin
  • Albuminuria
  • Apo A-I
  • Apo A-IV
  • Apo B
  • Apo E
  • Lipids

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Effect of Plasma Oncotic Pressure on Apolipoprotein Levels in Rats with Heymann Nephritis. / Kaysen, George; Jones, Hardin; Joles, Japp A.; Van Tol, Arie.

In: Mineral and Electrolyte Metabolism, Vol. 22, No. 1-3, 1996, p. 31-38.

Research output: Contribution to journalArticle

Kaysen, George ; Jones, Hardin ; Joles, Japp A. ; Van Tol, Arie. / Effect of Plasma Oncotic Pressure on Apolipoprotein Levels in Rats with Heymann Nephritis. In: Mineral and Electrolyte Metabolism. 1996 ; Vol. 22, No. 1-3. pp. 31-38.
@article{df223b742fdb4a80bdf0c38ff06297e9,
title = "Effect of Plasma Oncotic Pressure on Apolipoprotein Levels in Rats with Heymann Nephritis",
abstract = "The nephrotic syndrome is characterized by reduced plasma albumin and colloid osmotic pressure (π). Infusion of dextran or albumin reduces lipid levels suggesting that reduced plasma π plays a role in causing hyperlipidemia in the nephrotic syndrome. To determine whether apolipoprotein (Apo) levels were affected by π, passive Heymann nephritis (HN) was created in 20 rats. Hyperoncotic (25{\%}) human albumin or ficoll was infused continuously into each of 5 HN rats adjusted to maintain a plasma π above 20 mm Hg. Either saline or a mixture of amino acids calculated to approximate those released from catabolized human albumin were infused into 5 HN as controls. Urinary rat albumin loss was not different between the 4 groups of HN. Plasma apo A-I, B and E were all increased significantly in saline and amino acid infused HN, but apo A-IV was decreased. Infusion of either albumin or ficoll normalized apo A-I, and apo E levels in HN even though proteinuria continued unabated. In contrast, apo B remained significantly elevated in HN infused with albumin, but was reduced to normal by ficoll. Fifteen non-nephrotic control animals were studied in 3 groups of 5 animals each; one receiving human albumin, one ficoll, both adjusted to increase plasma π to supranormal levels, and a 3rd group received saline. In contrast to HN, plasma apo A-I, E, and B levels were unaffected by albumin or ficoll infusion in control animals. Ficoll caused a significant reduction in apo A-IV in both HN and control animals to subnormal levels, but albumin infusion was without effect. Reduced plasma π, but not reduced plasma albumin is necessary for increased apo A-I, and E levels in the nephrotic syndrome. When plasma π is normal extensive proteinuria does not increase plasma apo A-I or E levels. Factors other than albumin concentration or π, such as persistent urinary protein loss, play a role in establishing increased apo B containing lipoproteins in the nephrotic syndrome. Ficoll may cause changes in plasma lipoprotein levels by means other than its ability to increase plasma π.",
keywords = "Albumin, Albuminuria, Apo A-I, Apo A-IV, Apo B, Apo E, Lipids",
author = "George Kaysen and Hardin Jones and Joles, {Japp A.} and {Van Tol}, Arie",
year = "1996",
language = "English (US)",
volume = "22",
pages = "31--38",
journal = "Mineral and Electrolyte Metabolism",
issn = "0378-0392",
publisher = "S. Karger AG",
number = "1-3",

}

TY - JOUR

T1 - Effect of Plasma Oncotic Pressure on Apolipoprotein Levels in Rats with Heymann Nephritis

AU - Kaysen, George

AU - Jones, Hardin

AU - Joles, Japp A.

AU - Van Tol, Arie

PY - 1996

Y1 - 1996

N2 - The nephrotic syndrome is characterized by reduced plasma albumin and colloid osmotic pressure (π). Infusion of dextran or albumin reduces lipid levels suggesting that reduced plasma π plays a role in causing hyperlipidemia in the nephrotic syndrome. To determine whether apolipoprotein (Apo) levels were affected by π, passive Heymann nephritis (HN) was created in 20 rats. Hyperoncotic (25%) human albumin or ficoll was infused continuously into each of 5 HN rats adjusted to maintain a plasma π above 20 mm Hg. Either saline or a mixture of amino acids calculated to approximate those released from catabolized human albumin were infused into 5 HN as controls. Urinary rat albumin loss was not different between the 4 groups of HN. Plasma apo A-I, B and E were all increased significantly in saline and amino acid infused HN, but apo A-IV was decreased. Infusion of either albumin or ficoll normalized apo A-I, and apo E levels in HN even though proteinuria continued unabated. In contrast, apo B remained significantly elevated in HN infused with albumin, but was reduced to normal by ficoll. Fifteen non-nephrotic control animals were studied in 3 groups of 5 animals each; one receiving human albumin, one ficoll, both adjusted to increase plasma π to supranormal levels, and a 3rd group received saline. In contrast to HN, plasma apo A-I, E, and B levels were unaffected by albumin or ficoll infusion in control animals. Ficoll caused a significant reduction in apo A-IV in both HN and control animals to subnormal levels, but albumin infusion was without effect. Reduced plasma π, but not reduced plasma albumin is necessary for increased apo A-I, and E levels in the nephrotic syndrome. When plasma π is normal extensive proteinuria does not increase plasma apo A-I or E levels. Factors other than albumin concentration or π, such as persistent urinary protein loss, play a role in establishing increased apo B containing lipoproteins in the nephrotic syndrome. Ficoll may cause changes in plasma lipoprotein levels by means other than its ability to increase plasma π.

AB - The nephrotic syndrome is characterized by reduced plasma albumin and colloid osmotic pressure (π). Infusion of dextran or albumin reduces lipid levels suggesting that reduced plasma π plays a role in causing hyperlipidemia in the nephrotic syndrome. To determine whether apolipoprotein (Apo) levels were affected by π, passive Heymann nephritis (HN) was created in 20 rats. Hyperoncotic (25%) human albumin or ficoll was infused continuously into each of 5 HN rats adjusted to maintain a plasma π above 20 mm Hg. Either saline or a mixture of amino acids calculated to approximate those released from catabolized human albumin were infused into 5 HN as controls. Urinary rat albumin loss was not different between the 4 groups of HN. Plasma apo A-I, B and E were all increased significantly in saline and amino acid infused HN, but apo A-IV was decreased. Infusion of either albumin or ficoll normalized apo A-I, and apo E levels in HN even though proteinuria continued unabated. In contrast, apo B remained significantly elevated in HN infused with albumin, but was reduced to normal by ficoll. Fifteen non-nephrotic control animals were studied in 3 groups of 5 animals each; one receiving human albumin, one ficoll, both adjusted to increase plasma π to supranormal levels, and a 3rd group received saline. In contrast to HN, plasma apo A-I, E, and B levels were unaffected by albumin or ficoll infusion in control animals. Ficoll caused a significant reduction in apo A-IV in both HN and control animals to subnormal levels, but albumin infusion was without effect. Reduced plasma π, but not reduced plasma albumin is necessary for increased apo A-I, and E levels in the nephrotic syndrome. When plasma π is normal extensive proteinuria does not increase plasma apo A-I or E levels. Factors other than albumin concentration or π, such as persistent urinary protein loss, play a role in establishing increased apo B containing lipoproteins in the nephrotic syndrome. Ficoll may cause changes in plasma lipoprotein levels by means other than its ability to increase plasma π.

KW - Albumin

KW - Albuminuria

KW - Apo A-I

KW - Apo A-IV

KW - Apo B

KW - Apo E

KW - Lipids

UR - http://www.scopus.com/inward/record.url?scp=0029655770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029655770&partnerID=8YFLogxK

M3 - Article

C2 - 8676821

AN - SCOPUS:0029655770

VL - 22

SP - 31

EP - 38

JO - Mineral and Electrolyte Metabolism

JF - Mineral and Electrolyte Metabolism

SN - 0378-0392

IS - 1-3

ER -